MISSOULA – The National Institutes of Health has awarded the University of Montana a five-year, $33.4 million award for the development and clinical trials of opioid vaccines. It is the largest such award in University history.
The award was funded through the NIH HEAL Initiative, a national effort to speed scientific solutions to the national opioid health crisis. It includes funding for two Phase One clinical trials of opioid vaccines developed by UM’s Center for Translational Medicine in collaboration with Inimmune Corp. (Dr. Kendal Ryter and Dr. David Burkhart) and the University of Minnesota (Dr. Marco Pravetoni).
READ FULL ARTICLE
